A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects

NCT06948799 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Oligozoospermia

Interventions

DRUG: STSP-0902 injection
DRUG: Placebo

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd